The two proposed rules from the Drug Enforcement Administration (DEA) that effectively undue controlled substances prescribing via telehealth have received over 21,000 submissions so far during its public comment period.
The two proposed rules from the Drug Enforcement Administration (DEA) that effectively undue controlled substances prescribing via telehealth have received over 21,000 submissions so far during its public comment period.